PYRIDIUM DIN 00476714
Status: Marketed
Holder: SEARCHLIGHT PHARMA INC
Molecule: PHENAZOPYRIDINE HYDROCHLORIDE
Available to quote
Health Canada record
| Active ingredient(s) | PHENAZOPYRIDINE HYDROCHLORIDE 100 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | G04BX06 PHENAZOPYRIDINE |
| Original market date | 31-Dec-1981 |
| Current status date | 07-Jul-2025 |
| Source | Health Canada DPD |
Establishment licence of the holder
Searchlight Pharma Inc — licence 102247, currently licensed, last inspection rating C (2024-10-10).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing PHENAZOPYRIDINE HYDROCHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00271489 | PHENAZO | BAUSCH HEALTH, CANADA INC. | Tablet | PHENAZOPYRIDINE HYDROCHLORIDE 100 MG | Dormant |
| 00454583 | PHENAZO | BAUSCH HEALTH, CANADA INC. | Tablet | PHENAZOPYRIDINE HYDROCHLORIDE 200 MG | Dormant |
| 00385441 | PHENAZOPYRIDINE TAB 100MG | DUCHESNAY INC | Tablet | PHENAZOPYRIDINE HYDROCHLORIDE 100 MG | Cancelled Post Market |
| 00476722 | PYRIDIUM | SEARCHLIGHT PHARMA INC | Tablet | PHENAZOPYRIDINE HYDROCHLORIDE 200 MG | Dormant |
| 00156914 | PYRONIUM 0.1GM | PRO DOC LIMITEE | Tablet | PHENAZOPYRIDINE HYDROCHLORIDE 100 MG | Cancelled Post Market |
| 00386499 | PYRONIUM TAB 200MG | PRO DOC LIMITEE | Tablet | PHENAZOPYRIDINE HYDROCHLORIDE 200 MG | Cancelled Post Market |
International API supply for PHENAZOPYRIDINE HYDROCHLORIDE
1 active FDA Drug Master Files.
Request a quote for PYRIDIUM